|
1
|
Bird CC, McElin TW and Manalo-Estrella P:
The elusive adenomyosis of the uterus-revisited. Am J Obstet
Gynecol. 112:583–593. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mehasseb MK and Habiba MA: Adenomyosis
uteri: An update. Obstet Gynaecol. 11:41–47. 2009.
|
|
3
|
Bergholt T, Eriksen L, Berendt N, Jacobsen
M and Hertz JB: Prevalence and risk factors of adenomyosis at
hysterectomy. Hum Reprod. 16:2418–2421. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shrestha A, Shrestha R, Sedhai LB and
Pandit U: Adenomyosis at hysterectomy: Prevalence, patient
characteristics, clinical profile and histopathological findings.
Kathmandu Univ Med J (KUMJ). 10:53–56. 2012.PubMed/NCBI
|
|
5
|
Parazzini F, Mais V, Cipriani S, Busacca M
and Venturini P; GISE: Determinants of adenomyosis in women who
underwent hysterectomy for benign gynecological conditions: Results
from a prospective multicentric study in Italy. Eur J Obstet
Gynecol Reprod Biol. 143:103–106. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weiss G, Maseelall P, Schott LL, Brockwell
SE, Schocken M and Johnston JM: Adenomyosis a variant not a
disease? Evidence from hysterectomized menopausal women in the SWAN
study. Fertil Steril. 91:201–206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Molitor JJ: Adenomyosis: A clinical and
pathological appraisal. Am J Obstet Gynecol. 110:275–284. 1971.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vercellini P, Parazzini F, Oldani S,
Panazza S, Bramante T and Crosignani PG: Adenomyosis at
hysterectomy: A study on frequency distribution and patient
characteristics. Hum Reprod. 10:1160–1162. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yeniel O, Cirpan T, Ulukus M, Ozbal A,
Gundem G, Ozsener S, Zekioglu O and Yılmaz H: Adenomyosis:
Prevalence, risk factors, symptoms and clinical findings. Clin Exp
Obstet Gynecol. 34:163–167. 2007.PubMed/NCBI
|
|
10
|
Gordts S, Brosens JJ, Fusi L, Benagiano G
and Brosens I: Uterine adenomyosis: A need for uniform terminology
and consensus classification. Reprod Biomed Online. 17:244–248.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Azziz R: Adenomyosis: Current
perspectives. Obstet Gynecol Clin North Am. 16:221–235.
1989.PubMed/NCBI
|
|
12
|
Dayal S and Nagrath A: Pattern and
frequency of endometrial and ovarian pathologies with adenomyosis
uteri in patients who attended the tertiary care hospital among
rural population of North India. MAMC J Med Sci. 1:147–150. 2015.
View Article : Google Scholar
|
|
13
|
Arunachalam B and Manivasakan J: A
clinico-pathological study of adenomyosis. J Clin Diagnos Res.
6:428–430. 2012.
|
|
14
|
Uduwela AS, Perera MA, Aiqing L and Fraser
IS: Endometrial-myometrial interface: Relationship to adenomyosis
and changes in pregnancy. Obstet Gynecol Surv. 55:390–400. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Creasman W, Odicino F, Maisonneuve P,
Beller U, Benedet JL, Heintz AP, Ngan HY, Sideri M and Pecorelli S:
Carcinoma of the corpus uteri: FIGO annual report. J Epidemiol
Biostat. 6:47–86. 2001.PubMed/NCBI
|
|
16
|
Brierley JD, Gospodarowicz MK and
Wittekind C: TNM Classification of Malignant Tumors. 8th. Oxford,
UK: Wiley; 2016
|
|
17
|
Di Spiezio Sardo A, Calagna G, Santangelo
F, Zizolfi B, Tanos V, Perino A and De Wilde RL: The role of
hysterescopy in the diagnosis and treatment of adenomyosis. Biomed
Res Int. 2017:Article ID 2518396. 2017. View Article : Google Scholar
|
|
18
|
Siddegowda MS, Manjunath MR and Shivakumar
S: Occurrence of Adenomyosis in Hysterectomy Specimen and its
Clinical Correlation in a Tertiary Care Hospital in Mandya,
Karnataka, India. Inter J Sci Study. 3:61–64. 2015.
|
|
19
|
Anwar A: Incidence of adenomyosis in
hysterectomies. Pak J Med Res. 44:38–40. 2005.
|
|
20
|
Korzekewa AJ, Bah MM, Gestwicka M, Socha B
and Skarżyński DJ: Adenomyosis in the bovine uterus: Correlation
between frequency, age, and 17β-estradiol-progesterone equilibrium.
Theriogenology. 79:165–172. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Takahashi K, Nagata H and Kitao M:
Clinical usefulness of determination of estradiol levels in the
menstrual blood for patients with adenomyosis. Nihon Sanka Fujinka
Gakkai Zasshi. 41:1849–1850. 1989.PubMed/NCBI
|
|
22
|
Leyendecker G, Wildt I and Mall G: The
pathophysiology of endometriosis and adenomyosis: Tissue injury and
repair. Arch Gynecol Obstet. 280:529–538. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Leyendecker G and Wildt L: A new concept
of endometriosis and adenomyosis: Tissue injury and repair (TIAR).
Horm Mol Biol Clin Investig. 5:125–142. 2011.PubMed/NCBI
|
|
24
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Prat J: Prognostic parameters of
endometrial carcinoma. Hum Pathol. 35:649–662. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mittal KR and Barwick KW: Endometrial
adenocarcinoma involving adenomyosis without true myometrial
invasion is characterized by frequent preceding estrogen therapy,
low histologic grades, and excellent prognosis. Gynecol Oncol.
49:197–201. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jacques SM and Lawrence WD: Endometrial
adenocarcinoma with variable-level myometrial involvement limited
to adenomyosis: A clinicopathologic study of 23 cases. Gynecol
Oncol. 37:401–407. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hernandez E and Woodruff JD: Endometrial
adenocarcinoma arising in adenomyosis. Am J Obstet Gynecol.
138:827–832. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kucera E, Hejda V, Dankovcik R, Valha P,
Dudas M and Feyereisl J: Malignant changes in adenomyosis in
patients with endometrial adenocarcinoma. Eur J Gynecol Oncol.
32:182–184. 2011.
|
|
30
|
Ismiil N, Rasty G, Ghorab Z, Nofech-Mozes
S, Bernardini M, Ackerman I, Thomas G, Covens A and Khalifa MA:
Adenomyosis involved by endometrial adenocarcinoma is a significant
risk factor for deep myometrial invasion. Ann Diagn Pathol.
11:252–257. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Parazzini F, Vercellini P, Panazza S,
Chatenoud L, Oldani S and Crosignani PG: Risk factors for
adenomyosis. Hum Reprod. 12:1275–1279. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Urabe M, Yamamoto T, Kitawaki J, Honjo H
and Okada H: Estrogen biosynthesis in human uterine adenomyosis.
Acta Endocrinol (Copenh). 121:259–264. 1989.PubMed/NCBI
|
|
33
|
Yamamato T, Noguchi T, Tamura T, Kitawaki
J and Okada H: Evidence for estrogen synthesis in adenomyotic
tissues. Am J Obstet Gynecol. 169:734–738. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gizzo S, Patrelli TS, Dall'asta A, DI
Gangi S, Giordano G, Migliavacca C, Monica M, Meriso C, Nardelli
GB, Quranta M, et al: Coexistence of adenomyosis and endometrioid
endometrial cancer: Role in surgical guidance and prognosis
estimation. Oncol Lett. 11:1213–1219. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ismiil N, Rasty G, Ghorab Z, Nofech-Mozes
S, Bernardini M, Thomas G, Ackerman I, Covens A and Khalifa MA:
Adenomyosis is associated with myometrial invasion by FIGO1
endometrial adenocarcinoma. Int J Gynecol Pathol. 26:278–283. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Koike N, Tsunemi T, Uekuri C, Akasaka J,
Ito F, Shigemitsu A and Kobayashi H: Pathogenesis and malignant
transformation of adenomyosis (Review). Oncol Rep. 29:861–867.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Walter I, Handler J, Reifinger M and
Aurich C: Association of endometriosis in horses with
differentiation of periglandular myofibroblasts and changes of
extracellular matrix proteins. Reproduction. 121:581–586. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Van Kaam KJ, Schouten JP, Nap AW,
Dunselman GA and Groothuis PG: Fibromuscular differentiation in
deeply infiltrating endometriosis is a reaction of resident
fibroblasts to the presence of ectopic endometrium. Hum Reprod.
23:2692–2700. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hall JB, Young RH and Nelson JH Jr: The
prognostic significance of adenomyosis in endometrial carcinoma.
Gynecol Oncol. 17:32–40. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Koshiyama M, Okamoto T and Ueta M: The
relationship between endometrial carcinoma and coexistent
adenomyosis uteri, endometriosis externa and myoma uteri. Cancer
Detec Prev. 28:94–98. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Flake GP, Andersen J and Dixon D: Etiology
and pathogenesis of uterine leiomyomas: A review. Environ Health
Perspect. 111:1037–1054. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
42
|
Benassayag C, Leroy MJ, Rigourd V, Robert
B, Honoré JC, Mignot TM. Vacher-Lavenu MC, Chapron C and Ferré F:
Estrogen receptors (ERalpha/ERbeta) in normal and pathological
growth of the human myometrium: Pregnancy and leiomyoma. Am J
Physiol. 276:E1112–E1118. 1999.PubMed/NCBI
|
|
43
|
Kovács KA, Oszter A, Göcze PM, Környei JL
and Szabó: Comparative analysis of cyclin D1 and oestrogen receptor
(alpha and beta) levels in human leiomyoma and adjacent myometrium.
Mol Hum Repr. 7:1085–1091. 2001. View Article : Google Scholar
|
|
44
|
Shaikh H and Khan KS: Adenomyosis in
Pakistani women: Four year experience at the Aga Khan University
Medical centre, Karachi. J Clin Pathol. 43:817–819. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Leyendecker G, Kunz G, Kissler S and Wildt
L: Adenomyosis and reproduction. Best Pract Res Clin Obstet
Gyneacol. 20:523–546. 2006. View Article : Google Scholar
|
|
46
|
Mathur BB, Shah BS and Bhende YM:
Adenomyosis uteri. A pathologic study of 290 cases. Am J Obstet
Gynecol. 84:1820–1829. 1962. View Article : Google Scholar
|
|
47
|
Shrestha A and Sedai LB: Understanding
clinical features of adenomyosis: A case control study. Nepal Med
Coll J. 14:176–179. 2012.PubMed/NCBI
|
|
48
|
Wallwiener M, Taran FA, Rothmund R,
Kasperkowiak A, Auwärter G, Ganz A, Kraemer B, Abele H, Schönfisch
B, Isaacson KB and Brucker SY: Laparoscopic supracervical
hysterectomy (LSH) versus total laparoscopic hysterectomy (TLH): An
implementation study in 1,952 patients with an analysis of risk
factors for conversion to laparotomy and complications, and of
procedure-specific re-operations. Arch Gynecol Obstet.
288:1329–1339. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Polin SA and Ascher SM: The effect of
tamoxifen on the genital tract. Cancer Imaging. 8:135–145. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Deligdisch L: Effects of hormone therapy
on the endometrium. Mod Pathol. 6:94–106. 1993.PubMed/NCBI
|
|
51
|
Cohen I, Beyth Y, Tepper R, Figer A,
Shapira J, Cordoba M, Yigael D and Altaras MM: Adenomyosis in
postmenopausal breast cancer patients treated with tamoxifen: A new
entity? Gynecol Oncol. 58:86–91. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Taran FA, Stewart EA and Brucker S:
Adenomyosis: Epidemiology, risk factors, clinical phenotype and
surgical and interventional alternatives to hysterectomy.
Geburtshilfe Frauenheilkd. 73:924–931. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
McCluggage WG, Desai V and Manek S:
Tamoxifen-associated postmenopausal adenomyosis exhibits stromal
fibrosis, glandular dilatation and epithelial metaplasias.
Histopathology. 37:340–346. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Mehla S, Singh M and Chutani N:
Clinicopathological correlation of adenomyosis and leiomyoma in
hysterectomy specimens as the cause of abnormal uterine bleeding: A
retrospective study. Sch J App Med. 2:3320–3323. 2014.
|
|
55
|
İsaoğlu U, Yılmaz M, Delibaş I, Gözükara
I, Bilici AE, Uluğ P and Kabalar E: The Evaluation of
histopathologic diagnosis in specimens of hysterectomy. Abant Med
J. 2:91–94. 2013. View Article : Google Scholar
|
